ethyl 3-[3-ethoxy-1-(4-hydroxy-3-methoxybenzyl)-1H-pyrazol-4-yl]propionate

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: ethyl 3-[3-ethoxy-1-(4-hydroxy-3-methoxybenzyl)-1H-pyrazol-4-yl]propionate
• 英文别名: ethyl 3-[3-ethoxy-1-[(4-hydroxy-3-methoxyphenyl)methyl]pyrazol-4-yl]propanoate
• 化学式: C₁₈H₂₄N₂O₅
• 分子量: 348.399
• InChiKey: PGPTVAPEJYOWAG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  25
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  82.8
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  ethyl 3-[3-ethoxy-1-(4-hydroxy-3-methoxybenzyl)-1H-pyrazol-4-yl]propionate 、 碘乙烷 在 sodium hydride 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 1.5h， 以88%的产率得到ethyl 3-[3-ethoxy-1-[3-methoxy-4-(5-methyl-2-phenyl-4-oxazolylmethoxy)benzyl]-1H-pyrazol-4-yl]propionate
  参考文献：
  名称：

  EP1445254

  摘要：

  公开号：
• 作为产物：
  描述：

  ethyl 3-[1-(4-benzyloxy-3-methoxybenzyl)-3-ethoxy-1H-pyrazol-4-yl]propionate 在 5%-palladium/activated carbon 氢气 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 1.0h， 以89%的产率得到ethyl 3-[3-ethoxy-1-(4-hydroxy-3-methoxybenzyl)-1H-pyrazol-4-yl]propionate
  参考文献：
  名称：

  5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY

  摘要：

  公开号：

  EP1228067B1

文献信息

• PROCESS FOR PRODUCTION OF PYRAZOLE COMPOUNDS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1445254A1

  公开（公告）日：2004-08-11

  As a method capable of conveniently producing a pyrazole compound in a high yield, which is useful as a synthetic intermediate for a pharmaceutical agent such as a therapeutic agent for diabetes and the like, a production method of a compound represented by the formula (I) wherein n is an integer of 1 to 4 and R1 is a hydrocarbon group optionally having substituents, or a salt thereof, is provided, which includes reacting a compound represented by the formula (II) wherein Q is a hydroxy group optionally having substituents or an amino group optionally having substituents, R is a hydrocarbon group optionally having substituents and other symbols are as defined above, or a salt thereof, with hydrazine or a salt thereof.

  提供一种制备嘧唑烷化合物的方法，该方法能够方便地高产得到嘧唑烷化合物，该化合物可用作制药中间体，例如治疗糖尿病等治疗剂的合成中间体。该制备方法包括将式（II）所表示的化合物与肼或其盐反应，其中n为1至4的整数，R1为具有取代基的烃基或其盐。式（II）中Q为具有取代基的羟基或氨基，R为具有取代基的烃基，其他符号如上所定义。
• Process for production of pyrazole compounds
  申请人：Tawada Hiroyuki

  公开号：US20050014813A1

  公开（公告）日：2005-01-20

  As a method capable of conveniently producing a pyrazole compound in a high yield, which is useful as a synthetic intermediate for a pharmaceutical agent such as a therapeutic agent for diabetes and the like, a production method of a compound represented by the formula (I) wherein n is an integer of 1 to 4 and R 1 is a. hydrocarbon group optionally having substituents, or a salt thereof, is provided, which includes reacting a compound represented by the formula, (II) wherein Q is a hydroxy group optionally having substituents or an amino group optionally having substituents, R is a hydrocarbon group optionally having substituents and other symbols are as defined above, or a salt thereof, with hydrazine or a salt thereof.

  作为一种能够方便地高产生产吡唑烷化合物的方法，该方法对于制备药物中间体如治疗糖尿病等治疗剂非常有用，提供了一种化合物的生产方法，该化合物由式（I）所表示，其中n是1至4的整数，R1是一个烃基，可选择地具有取代基，或其盐，包括将由式（II）所表示的化合物与肼或其盐反应，其中Q是一个羟基，可选择地具有取代基，或一个氨基，可选择地具有取代基，R是一个烃基，可选择地具有取代基，其他符号如上所定义。
• 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US07179823B1

  公开（公告）日：2007-02-20

  A compound of formula (I) F wherein R1 represents a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; x represents a bond, an oxygen atom, a sulfur atom, or a group of the formula: —CO—, —CS—, —CR4(OR5)— or —NR6— wherein each of R4 and R6 represents a hydrogen atom or a hydrocarbon group which may be stubstituted, R5 represents a hydrogen atom or a protective group for a hydroxyl group; m represents an integer of 0 to 3; Y represents an oxygen atom, a sulfur atom, or a group of the formula: —SO—, —SO2—, —NR7—, —CONR7— or —NR7CO— wherein R7 represents a hydrogen atom or a hydrocarbon group which may be substituted; ring A represents an aromatic ring which may further have 1 to 3 substituents; n represents an integer of 1 to 8; ring B represents a nitrogen-containing 5-membered hetero ring which may further be substituted by an alkyl group.

  化合物的式子为（I）F，其中R1代表一个可以被取代的碳氢基团或杂环基团；x代表一个键、一个氧原子、一个硫原子或者一个式子为：—CO—、—CS—、—CR4(OR5)—或—NR6—的基团，其中R4和R6分别代表一个氢原子或者一个可以被取代的碳氢基团，R5代表一个氢原子或者一个羟基的保护基团；m代表一个0到3的整数；Y代表一个氧原子、一个硫原子或者一个式子为：—SO—、—SO2—、—NR7—、—CONR7—或—NR7CO—的基团，其中R7代表一个氢原子或者一个可以被取代的碳氢基团；环A代表一个芳香环，可以有1到3个取代基；n代表一个1到8的整数；环B代表一个含氮的5元杂环，可以有一个烷基的取代基。
• 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1457490A1

  公开（公告）日：2004-09-15

  Use of a compound of the formula: wherein R1 represents a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; X represents a bond, an oxygen atom, a sulfur atom, or a group of the formula: -CO-, -CS-, -CR4(OR5)- or -NR6- wherein each of R4 and R6 represents a hydrogen atom or a hydrocarbon group which may be substituted, R5 represents a hydrogen atom or a protective group for a hydroxyl group; m represents an integer of 0 to 3; Y represents an oxygen atom, a sulfur atom, or a group of the formula: -SO-, -SO2-, -NR7-, -CONR7- or -NR7CO- wherein R7 represents a hydrogen atom or a hydrocarbon group which may be substituted; ring A represents an aromatic ring which may further have 1 to 3 substituents; n represents an integer of 1 to 8; ring B represents a nitrogen-containing 5-membered hetero ring which may further be substituted by an alkyl group; X1 represents a bond, an oxygen atom, a sulfur atom, or a group of the formula: -SO-, -SO2-, -O-SO2- or -NR16- wherein R16 represents a hydrogen atom or a hydrocarbon group which may be substituted; R2 represents a hydrogen atom, a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; W represents a bond or a divalent hydrocarbon residue having 1 to 20 carbon atoms; R3 represents a group of the formula: -OR8 (R8 represents a hydrogen atom or a hydrocarbon group which may be substituted) or -NR9R10 (each of R9 and R10, whether identical or not, represents a hydrogen atom, a hydrocarbon group which may be substituted, a heterocyclic group which may be substituted, or an acyl group which may be substituted; R9 and R10 may bind together to form a ring); or a salt thereof, for the manufacture of a pharmaceutical preparation for preventing or treating syndrome X.

  式化合物的用途： 其中 R1 代表可被取代的烃基或可被取代的杂环基； X 代表键、氧原子、硫原子或式中的基团：-其中 R4 和 R6 分别代表氢原子或可被取代的烃基，R5 代表氢原子或羟基的保护基团； m 代表 0 至 3 的整数； Y 代表氧原子、硫原子或式中的一个基团：-其中 R7 代表氢原子或可被取代的烃基； 环 A 代表芳香环，可进一步具有 1 至 3 个取代基； n 代表 1 至 8 的整数； 环 B 代表含氮 5 元杂环，可进一步被烷基取代； X1 代表键、氧原子、硫原子或式中的基团：-其中 R16 代表氢原子或可被取代的烃基； R2 代表氢原子、可被取代的烃基或可被取代的杂环基； W 代表键或具有 1 至 20 个碳原子的二价烃残基； R3 代表式中的一个基团：-OR8(R8代表氢原子或可被取代的烃基)或-NR9R10(R9和R10，无论是否相同，各自代表氢原子、可被取代的烃基、可被取代的杂环基或可被取代的酰基；R9和R10可结合在一起形成环)；或其盐、 用于制造预防或治疗 X 综合征的药物制剂。
• 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGYLCEMIC AND HYPOLIPIDEMIC ACTIVITY
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1228067A1

  公开（公告）日：2002-08-07